Geopolitics Alpha

PRI, ERM partner on healthcare sustainability value creation guidance

Published . Updated .

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.

GEOPOLITICS ALPHAPRI, ERM partner on healthcaresustainability value creationguidanceGEOPOLITICS ALPHA

This report is about pharma and health.

Directly affected

  • No company is named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story.

  • XBI SPDR S&P Biotech ETF

    SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story.

  • LLY Eli Lilly and+25.1% 30d

    Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.

  • JNJ Johnson & Johnson+12.1% 30d

    Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.

  • PFE Pfizer+5.2% 30d

    Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.

  • MRK Merck+3.5% 30d

    Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
XLV+0.52%-0.04%baseafter closeafter closeafter closeafter close
XBI+6.26%+3.61%baseafter closeafter closeafter closeafter close
LLY-0.12%-0.28%baseafter closeafter closeafter closeafter close
JNJ-0.65%+0.33%baseafter closeafter closeafter closeafter close
PFE+1.66%-0.17%baseafter closeafter closeafter closeafter close
MRK+2.39%+1.67%baseafter closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

PRI, ERM partner on healthcare sustainability value creation guidance New Private Markets

Source: New Private Markets

This story

CompanyWhenMoveStatus
JNJthree days earlier+0.33%final price
JNJfive days earlier-0.65%final price
LLYthree days earlier-0.28%final price
LLYfive days earlier-0.12%final price
MRKthree days earlier+1.67%final price
MRKfive days earlier+2.39%final price
PFEthree days earlier-0.17%final price
PFEfive days earlier+1.66%final price
XBIthree days earlier+3.61%final price
XBIfive days earlier+6.26%final price
XLVthree days earlier-0.04%final price
XLVfive days earlier+0.52%final price

Trades by members of Congress and officials in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

This story

12 out of 100

“PRI, ERM partner on healthcare sustainability value creation guidance” scores 12 out of 100. The score uses 1 sources.